nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—peripheral nervous system neoplasm—malignant glioma	0.409	1	CtDrD
Doxorubicin—POR—malignant glioma	0.214	0.568	CbGaD
Doxorubicin—TOP2A—malignant glioma	0.086	0.228	CbGaD
Doxorubicin—CYP2B6—malignant glioma	0.0764	0.203	CbGaD
Doxorubicin—NOS3—umbilical vein—malignant glioma	0.00193	0.0402	CbGeAlD
Doxorubicin—NOS1—endothelium—malignant glioma	0.0012	0.0251	CbGeAlD
Doxorubicin—CBR3—embryo—malignant glioma	0.00113	0.0236	CbGeAlD
Doxorubicin—NOS1—blood vessel—malignant glioma	0.00111	0.0231	CbGeAlD
Doxorubicin—Valrubicin—TOP2A—malignant glioma	0.00109	0.324	CrCbGaD
Doxorubicin—ABCB8—telencephalon—malignant glioma	0.000957	0.0199	CbGeAlD
Doxorubicin—NOS3—endothelium—malignant glioma	0.000916	0.0191	CbGeAlD
Doxorubicin—NOS3—blood vessel—malignant glioma	0.000845	0.0176	CbGeAlD
Doxorubicin—Daunorubicin—POR—malignant glioma	0.000833	0.249	CrCbGaD
Doxorubicin—AKR1A1—retina—malignant glioma	0.000773	0.0161	CbGeAlD
Doxorubicin—AKR1A1—telencephalon—malignant glioma	0.000711	0.0148	CbGeAlD
Doxorubicin—NDUFS7—telencephalon—malignant glioma	0.000646	0.0135	CbGeAlD
Doxorubicin—Idarubicin—TOP2A—malignant glioma	0.000624	0.186	CrCbGaD
Doxorubicin—NOS1—brainstem—malignant glioma	0.000607	0.0126	CbGeAlD
Doxorubicin—NDUFS3—brainstem—malignant glioma	0.000596	0.0124	CbGeAlD
Doxorubicin—NOS1—retina—malignant glioma	0.000586	0.0122	CbGeAlD
Doxorubicin—NDUFS2—retina—malignant glioma	0.000582	0.0121	CbGeAlD
Doxorubicin—AKR1A1—medulla oblongata—malignant glioma	0.000559	0.0116	CbGeAlD
Doxorubicin—DHCR7—retina—malignant glioma	0.000546	0.0114	CbGeAlD
Doxorubicin—ABCB8—central nervous system—malignant glioma	0.000544	0.0113	CbGeAlD
Doxorubicin—NOS1—telencephalon—malignant glioma	0.000539	0.0112	CbGeAlD
Doxorubicin—NDUFS2—telencephalon—malignant glioma	0.000536	0.0111	CbGeAlD
Doxorubicin—ABCC6—retina—malignant glioma	0.000533	0.0111	CbGeAlD
Doxorubicin—ABCB8—cerebellum—malignant glioma	0.000532	0.0111	CbGeAlD
Doxorubicin—NDUFS3—telencephalon—malignant glioma	0.000529	0.011	CbGeAlD
Doxorubicin—CBR3—central nervous system—malignant glioma	0.000524	0.0109	CbGeAlD
Doxorubicin—CBR3—cerebellum—malignant glioma	0.000512	0.0107	CbGeAlD
Doxorubicin—AKR1A1—midbrain—malignant glioma	0.000511	0.0106	CbGeAlD
Doxorubicin—DHCR7—telencephalon—malignant glioma	0.000503	0.0105	CbGeAlD
Doxorubicin—YWHAG—retina—malignant glioma	0.000501	0.0104	CbGeAlD
Doxorubicin—AKR1A1—spinal cord—malignant glioma	0.000498	0.0104	CbGeAlD
Doxorubicin—Oral candidiasis—Carmustine—malignant glioma	0.000476	0.0061	CcSEcCtD
Doxorubicin—Epirubicin—TOP2A—malignant glioma	0.000473	0.141	CrCbGaD
Doxorubicin—NDUFS7—midbrain—malignant glioma	0.000464	0.00966	CbGeAlD
Doxorubicin—YWHAG—telencephalon—malignant glioma	0.000461	0.0096	CbGeAlD
Doxorubicin—Oral candidiasis—Temozolomide—malignant glioma	0.00046	0.0059	CcSEcCtD
Doxorubicin—Embolism—Temozolomide—malignant glioma	0.000455	0.00584	CcSEcCtD
Doxorubicin—NDUFS7—spinal cord—malignant glioma	0.000453	0.00943	CbGeAlD
Doxorubicin—RALBP1—retina—malignant glioma	0.000453	0.00942	CbGeAlD
Doxorubicin—Cyst—Carmustine—malignant glioma	0.000452	0.0058	CcSEcCtD
Doxorubicin—Parosmia—Temozolomide—malignant glioma	0.00045	0.00578	CcSEcCtD
Doxorubicin—Hypokinesia—Carmustine—malignant glioma	0.000447	0.00574	CcSEcCtD
Doxorubicin—Burning sensation—Carmustine—malignant glioma	0.000435	0.00558	CcSEcCtD
Doxorubicin—ABCB8—brain—malignant glioma	0.000432	0.00899	CbGeAlD
Doxorubicin—Thrombosis—Carmustine—malignant glioma	0.000427	0.00548	CcSEcCtD
Doxorubicin—NOS1—medulla oblongata—malignant glioma	0.000423	0.00881	CbGeAlD
Doxorubicin—NDUFS2—medulla oblongata—malignant glioma	0.000421	0.00876	CbGeAlD
Doxorubicin—RALBP1—telencephalon—malignant glioma	0.000417	0.00867	CbGeAlD
Doxorubicin—NDUFS3—medulla oblongata—malignant glioma	0.000416	0.00865	CbGeAlD
Doxorubicin—CBR3—brain—malignant glioma	0.000416	0.00865	CbGeAlD
Doxorubicin—Lung disorder—Temozolomide—malignant glioma	0.000412	0.00529	CcSEcCtD
Doxorubicin—NOS3—telencephalon—malignant glioma	0.00041	0.00853	CbGeAlD
Doxorubicin—AKR1A1—central nervous system—malignant glioma	0.000404	0.00841	CbGeAlD
Doxorubicin—Scotoma—Carmustine—malignant glioma	0.000398	0.00511	CcSEcCtD
Doxorubicin—AKR1A1—cerebellum—malignant glioma	0.000395	0.00822	CbGeAlD
Doxorubicin—DHCR7—medulla oblongata—malignant glioma	0.000395	0.00822	CbGeAlD
Doxorubicin—Vaginal haemorrhage—Temozolomide—malignant glioma	0.000394	0.00506	CcSEcCtD
Doxorubicin—CBR1—telencephalon—malignant glioma	0.000389	0.00809	CbGeAlD
Doxorubicin—Herpes zoster—Temozolomide—malignant glioma	0.000388	0.00498	CcSEcCtD
Doxorubicin—Necrosis—Carmustine—malignant glioma	0.000385	0.00494	CcSEcCtD
Doxorubicin—NDUFS2—midbrain—malignant glioma	0.000385	0.00801	CbGeAlD
Doxorubicin—Scotoma—Temozolomide—malignant glioma	0.000384	0.00493	CcSEcCtD
Doxorubicin—Abscess—Carmustine—malignant glioma	0.000382	0.0049	CcSEcCtD
Doxorubicin—NDUFS3—midbrain—malignant glioma	0.00038	0.00791	CbGeAlD
Doxorubicin—NOS1—spinal cord—malignant glioma	0.000378	0.00786	CbGeAlD
Doxorubicin—NDUFS2—spinal cord—malignant glioma	0.000375	0.00781	CbGeAlD
Doxorubicin—Otitis media—Temozolomide—malignant glioma	0.000375	0.00481	CcSEcCtD
Doxorubicin—Hyperaesthesia—Temozolomide—malignant glioma	0.000372	0.00477	CcSEcCtD
Doxorubicin—NDUFS3—spinal cord—malignant glioma	0.000371	0.00771	CbGeAlD
Doxorubicin—Injection site pain—Carmustine—malignant glioma	0.00037	0.00475	CcSEcCtD
Doxorubicin—NDUFS7—central nervous system—malignant glioma	0.000367	0.00765	CbGeAlD
Doxorubicin—YWHAG—medulla oblongata—malignant glioma	0.000362	0.00754	CbGeAlD
Doxorubicin—DHCR7—midbrain—malignant glioma	0.000361	0.00751	CbGeAlD
Doxorubicin—NDUFS7—cerebellum—malignant glioma	0.000359	0.00747	CbGeAlD
Doxorubicin—Rigors—Temozolomide—malignant glioma	0.000358	0.00459	CcSEcCtD
Doxorubicin—Petechiae—Temozolomide—malignant glioma	0.000355	0.00455	CcSEcCtD
Doxorubicin—DHCR7—spinal cord—malignant glioma	0.000352	0.00733	CbGeAlD
Doxorubicin—Liver injury—Temozolomide—malignant glioma	0.000347	0.00445	CcSEcCtD
Doxorubicin—Extravasation—Carmustine—malignant glioma	0.000346	0.00444	CcSEcCtD
Doxorubicin—AURKA—central nervous system—malignant glioma	0.000342	0.00711	CbGeAlD
Doxorubicin—NQO1—retina—malignant glioma	0.000339	0.00705	CbGeAlD
Doxorubicin—Daunorubicin—TOP2A—malignant glioma	0.000335	0.0998	CrCbGaD
Doxorubicin—Breast pain—Temozolomide—malignant glioma	0.000335	0.0043	CcSEcCtD
Doxorubicin—Amenorrhoea—Temozolomide—malignant glioma	0.000332	0.00426	CcSEcCtD
Doxorubicin—YWHAG—midbrain—malignant glioma	0.000331	0.00689	CbGeAlD
Doxorubicin—Thinking abnormal—Carmustine—malignant glioma	0.00033	0.00424	CcSEcCtD
Doxorubicin—RALBP1—medulla oblongata—malignant glioma	0.000327	0.00681	CbGeAlD
Doxorubicin—Viral infection—Temozolomide—malignant glioma	0.000323	0.00415	CcSEcCtD
Doxorubicin—YWHAG—spinal cord—malignant glioma	0.000323	0.00673	CbGeAlD
Doxorubicin—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.000321	0.00412	CcSEcCtD
Doxorubicin—AKR1A1—brain—malignant glioma	0.000321	0.00668	CbGeAlD
Doxorubicin—Herpes simplex—Temozolomide—malignant glioma	0.000317	0.00407	CcSEcCtD
Doxorubicin—NQO1—telencephalon—malignant glioma	0.000312	0.00648	CbGeAlD
Doxorubicin—Gait disturbance—Carmustine—malignant glioma	0.00031	0.00397	CcSEcCtD
Doxorubicin—Coordination abnormal—Carmustine—malignant glioma	0.000308	0.00395	CcSEcCtD
Doxorubicin—NOS1—central nervous system—malignant glioma	0.000306	0.00638	CbGeAlD
Doxorubicin—Neck pain—Carmustine—malignant glioma	0.000306	0.00392	CcSEcCtD
Doxorubicin—CBR1—medulla oblongata—malignant glioma	0.000306	0.00636	CbGeAlD
Doxorubicin—NDUFS2—central nervous system—malignant glioma	0.000304	0.00634	CbGeAlD
Doxorubicin—Pulmonary embolism—Carmustine—malignant glioma	0.000302	0.00388	CcSEcCtD
Doxorubicin—AKR1C3—medulla oblongata—malignant glioma	0.000302	0.00628	CbGeAlD
Doxorubicin—NDUFS3—central nervous system—malignant glioma	0.000301	0.00626	CbGeAlD
Doxorubicin—Injection site reaction—Carmustine—malignant glioma	0.0003	0.00385	CcSEcCtD
Doxorubicin—NOS1—cerebellum—malignant glioma	0.000299	0.00623	CbGeAlD
Doxorubicin—RALBP1—midbrain—malignant glioma	0.000299	0.00623	CbGeAlD
Doxorubicin—Gait disturbance—Temozolomide—malignant glioma	0.000299	0.00384	CcSEcCtD
Doxorubicin—NDUFS2—cerebellum—malignant glioma	0.000298	0.00619	CbGeAlD
Doxorubicin—Coordination abnormal—Temozolomide—malignant glioma	0.000297	0.00382	CcSEcCtD
Doxorubicin—Musculoskeletal pain—Temozolomide—malignant glioma	0.000295	0.00379	CcSEcCtD
Doxorubicin—NDUFS3—cerebellum—malignant glioma	0.000294	0.00612	CbGeAlD
Doxorubicin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000292	0.00375	CcSEcCtD
Doxorubicin—Vaginal inflammation—Temozolomide—malignant glioma	0.000292	0.00375	CcSEcCtD
Doxorubicin—Pulmonary embolism—Temozolomide—malignant glioma	0.000292	0.00375	CcSEcCtD
Doxorubicin—RALBP1—spinal cord—malignant glioma	0.000292	0.00607	CbGeAlD
Doxorubicin—NDUFS7—brain—malignant glioma	0.000292	0.00607	CbGeAlD
Doxorubicin—Candida infection—Carmustine—malignant glioma	0.000288	0.0037	CcSEcCtD
Doxorubicin—Skin exfoliation—Carmustine—malignant glioma	0.000288	0.0037	CcSEcCtD
Doxorubicin—DHCR7—central nervous system—malignant glioma	0.000286	0.00595	CbGeAlD
Doxorubicin—Neuropathy—Carmustine—malignant glioma	0.000284	0.00364	CcSEcCtD
Doxorubicin—Influenza like illness—Temozolomide—malignant glioma	0.000284	0.00364	CcSEcCtD
Doxorubicin—DHCR7—cerebellum—malignant glioma	0.000279	0.00581	CbGeAlD
Doxorubicin—CBR1—midbrain—malignant glioma	0.000279	0.00581	CbGeAlD
Doxorubicin—Candida infection—Temozolomide—malignant glioma	0.000279	0.00358	CcSEcCtD
Doxorubicin—Skin exfoliation—Temozolomide—malignant glioma	0.000279	0.00358	CcSEcCtD
Doxorubicin—ABCC10—telencephalon—malignant glioma	0.000278	0.00579	CbGeAlD
Doxorubicin—Coma—Carmustine—malignant glioma	0.000276	0.00354	CcSEcCtD
Doxorubicin—AKR1C3—midbrain—malignant glioma	0.000276	0.00574	CbGeAlD
Doxorubicin—Vaginal infection—Temozolomide—malignant glioma	0.000276	0.00354	CcSEcCtD
Doxorubicin—POR—medulla oblongata—malignant glioma	0.000276	0.00573	CbGeAlD
Doxorubicin—Neuropathy—Temozolomide—malignant glioma	0.000274	0.00352	CcSEcCtD
Doxorubicin—Aplastic anaemia—Temozolomide—malignant glioma	0.000274	0.00352	CcSEcCtD
Doxorubicin—Neoplasm—Carmustine—malignant glioma	0.000273	0.00351	CcSEcCtD
Doxorubicin—CBR1—spinal cord—malignant glioma	0.000272	0.00567	CbGeAlD
Doxorubicin—AURKA—brain—malignant glioma	0.000271	0.00564	CbGeAlD
Doxorubicin—Dry eye—Temozolomide—malignant glioma	0.00027	0.00346	CcSEcCtD
Doxorubicin—AKR1C3—spinal cord—malignant glioma	0.000269	0.0056	CbGeAlD
Doxorubicin—Neoplasm—Temozolomide—malignant glioma	0.000264	0.00339	CcSEcCtD
Doxorubicin—Abnormal vision—Carmustine—malignant glioma	0.000263	0.00338	CcSEcCtD
Doxorubicin—YWHAG—central nervous system—malignant glioma	0.000262	0.00546	CbGeAlD
Doxorubicin—Sepsis—Carmustine—malignant glioma	0.000262	0.00337	CcSEcCtD
Doxorubicin—Mental disability—Carmustine—malignant glioma	0.000262	0.00337	CcSEcCtD
Doxorubicin—YWHAG—cerebellum—malignant glioma	0.000256	0.00533	CbGeAlD
Doxorubicin—Abnormal vision—Temozolomide—malignant glioma	0.000255	0.00327	CcSEcCtD
Doxorubicin—Phlebitis—Carmustine—malignant glioma	0.000255	0.00327	CcSEcCtD
Doxorubicin—Mental disability—Temozolomide—malignant glioma	0.000253	0.00325	CcSEcCtD
Doxorubicin—Thrombophlebitis—Carmustine—malignant glioma	0.000253	0.00325	CcSEcCtD
Doxorubicin—Diabetes mellitus—Carmustine—malignant glioma	0.000252	0.00324	CcSEcCtD
Doxorubicin—POR—midbrain—malignant glioma	0.000252	0.00524	CbGeAlD
Doxorubicin—POR—spinal cord—malignant glioma	0.000246	0.00511	CbGeAlD
Doxorubicin—Thrombophlebitis—Temozolomide—malignant glioma	0.000245	0.00314	CcSEcCtD
Doxorubicin—NQO1—medulla oblongata—malignant glioma	0.000245	0.00509	CbGeAlD
Doxorubicin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000244	0.00313	CcSEcCtD
Doxorubicin—NOS1—brain—malignant glioma	0.000243	0.00506	CbGeAlD
Doxorubicin—Eye pain—Carmustine—malignant glioma	0.000243	0.00312	CcSEcCtD
Doxorubicin—NDUFS2—brain—malignant glioma	0.000242	0.00503	CbGeAlD
Doxorubicin—NDUFS3—brain—malignant glioma	0.000239	0.00497	CbGeAlD
Doxorubicin—Vascular purpura—Temozolomide—malignant glioma	0.000237	0.00304	CcSEcCtD
Doxorubicin—RALBP1—central nervous system—malignant glioma	0.000237	0.00493	CbGeAlD
Doxorubicin—Hepatic failure—Temozolomide—malignant glioma	0.000236	0.00303	CcSEcCtD
Doxorubicin—Eye pain—Temozolomide—malignant glioma	0.000235	0.00301	CcSEcCtD
Doxorubicin—NOS3—central nervous system—malignant glioma	0.000233	0.00485	CbGeAlD
Doxorubicin—RALBP1—cerebellum—malignant glioma	0.000231	0.00482	CbGeAlD
Doxorubicin—DHCR7—brain—malignant glioma	0.000227	0.00472	CbGeAlD
Doxorubicin—Hot flush—Temozolomide—malignant glioma	0.000227	0.00291	CcSEcCtD
Doxorubicin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000225	0.00288	CcSEcCtD
Doxorubicin—Menopausal symptoms—Temozolomide—malignant glioma	0.000225	0.00288	CcSEcCtD
Doxorubicin—NQO1—midbrain—malignant glioma	0.000224	0.00466	CbGeAlD
Doxorubicin—CBR1—central nervous system—malignant glioma	0.000221	0.0046	CbGeAlD
Doxorubicin—Hyponatraemia—Carmustine—malignant glioma	0.00022	0.00283	CcSEcCtD
Doxorubicin—Purpura—Temozolomide—malignant glioma	0.00022	0.00282	CcSEcCtD
Doxorubicin—Diplopia—Carmustine—malignant glioma	0.000219	0.00281	CcSEcCtD
Doxorubicin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000219	0.00281	CcSEcCtD
Doxorubicin—CYP1B1—telencephalon—malignant glioma	0.000219	0.00455	CbGeAlD
Doxorubicin—ABCC10—medulla oblongata—malignant glioma	0.000219	0.00455	CbGeAlD
Doxorubicin—NQO1—spinal cord—malignant glioma	0.000218	0.00454	CbGeAlD
Doxorubicin—CBR1—cerebellum—malignant glioma	0.000216	0.0045	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—malignant glioma	0.000213	0.00444	CbGeAlD
Doxorubicin—Diplopia—Temozolomide—malignant glioma	0.000212	0.00272	CcSEcCtD
Doxorubicin—Face oedema—Carmustine—malignant glioma	0.000212	0.00272	CcSEcCtD
Doxorubicin—Affect lability—Temozolomide—malignant glioma	0.000209	0.00268	CcSEcCtD
Doxorubicin—YWHAG—brain—malignant glioma	0.000208	0.00433	CbGeAlD
Doxorubicin—Ataxia—Carmustine—malignant glioma	0.000206	0.00265	CcSEcCtD
Doxorubicin—Face oedema—Temozolomide—malignant glioma	0.000205	0.00263	CcSEcCtD
Doxorubicin—Liver function test abnormal—Carmustine—malignant glioma	0.000202	0.0026	CcSEcCtD
Doxorubicin—Mood swings—Temozolomide—malignant glioma	0.000201	0.00258	CcSEcCtD
Doxorubicin—ABCC10—midbrain—malignant glioma	0.0002	0.00416	CbGeAlD
Doxorubicin—Hypokalaemia—Carmustine—malignant glioma	0.0002	0.00256	CcSEcCtD
Doxorubicin—Ataxia—Temozolomide—malignant glioma	0.000199	0.00256	CcSEcCtD
Doxorubicin—Dehydration—Temozolomide—malignant glioma	0.000197	0.00253	CcSEcCtD
Doxorubicin—ABCC1—telencephalon—malignant glioma	0.000197	0.0041	CbGeAlD
Doxorubicin—ABCC10—spinal cord—malignant glioma	0.000195	0.00406	CbGeAlD
Doxorubicin—POR—cerebellum—malignant glioma	0.000195	0.00405	CbGeAlD
Doxorubicin—Dry skin—Temozolomide—malignant glioma	0.000194	0.00249	CcSEcCtD
Doxorubicin—Muscular weakness—Carmustine—malignant glioma	0.000193	0.00248	CcSEcCtD
Doxorubicin—Hypokalaemia—Temozolomide—malignant glioma	0.000193	0.00248	CcSEcCtD
Doxorubicin—Breast disorder—Temozolomide—malignant glioma	0.000191	0.00246	CcSEcCtD
Doxorubicin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000191	0.00245	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000191	0.00245	CcSEcCtD
Doxorubicin—Dysphagia—Carmustine—malignant glioma	0.00019	0.00243	CcSEcCtD
Doxorubicin—RALBP1—brain—malignant glioma	0.000188	0.00391	CbGeAlD
Doxorubicin—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000187	0.0024	CcSEcCtD
Doxorubicin—Muscular weakness—Temozolomide—malignant glioma	0.000187	0.0024	CcSEcCtD
Doxorubicin—NOS3—brain—malignant glioma	0.000185	0.00385	CbGeAlD
Doxorubicin—Abdominal distension—Temozolomide—malignant glioma	0.000184	0.00237	CcSEcCtD
Doxorubicin—Dysphagia—Temozolomide—malignant glioma	0.000183	0.00235	CcSEcCtD
Doxorubicin—Pancytopenia—Carmustine—malignant glioma	0.00018	0.00231	CcSEcCtD
Doxorubicin—Neutropenia—Carmustine—malignant glioma	0.000177	0.00227	CcSEcCtD
Doxorubicin—NQO1—central nervous system—malignant glioma	0.000177	0.00369	CbGeAlD
Doxorubicin—Bronchitis—Temozolomide—malignant glioma	0.000176	0.00226	CcSEcCtD
Doxorubicin—CBR1—brain—malignant glioma	0.000175	0.00365	CbGeAlD
Doxorubicin—Pancytopenia—Temozolomide—malignant glioma	0.000174	0.00223	CcSEcCtD
Doxorubicin—AKR1C3—brain—malignant glioma	0.000173	0.00361	CbGeAlD
Doxorubicin—NQO1—cerebellum—malignant glioma	0.000173	0.0036	CbGeAlD
Doxorubicin—Dysuria—Temozolomide—malignant glioma	0.000171	0.0022	CcSEcCtD
Doxorubicin—Neutropenia—Temozolomide—malignant glioma	0.000171	0.0022	CcSEcCtD
Doxorubicin—Hyperglycaemia—Carmustine—malignant glioma	0.000171	0.00219	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00017	0.00219	CcSEcCtD
Doxorubicin—Pneumonia—Carmustine—malignant glioma	0.00017	0.00218	CcSEcCtD
Doxorubicin—Pollakiuria—Temozolomide—malignant glioma	0.000169	0.00217	CcSEcCtD
Doxorubicin—Photosensitivity reaction—Temozolomide—malignant glioma	0.000167	0.00215	CcSEcCtD
Doxorubicin—Weight increased—Temozolomide—malignant glioma	0.000167	0.00214	CcSEcCtD
Doxorubicin—Renal failure—Carmustine—malignant glioma	0.000166	0.00213	CcSEcCtD
Doxorubicin—Weight decreased—Temozolomide—malignant glioma	0.000166	0.00213	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Carmustine—malignant glioma	0.000166	0.00213	CcSEcCtD
Doxorubicin—ABCB1—blood vessel—malignant glioma	0.000166	0.00345	CbGeAlD
Doxorubicin—Hyperglycaemia—Temozolomide—malignant glioma	0.000165	0.00212	CcSEcCtD
Doxorubicin—Stomatitis—Carmustine—malignant glioma	0.000165	0.00211	CcSEcCtD
Doxorubicin—Urinary tract infection—Carmustine—malignant glioma	0.000164	0.00211	CcSEcCtD
Doxorubicin—Pneumonia—Temozolomide—malignant glioma	0.000164	0.00211	CcSEcCtD
Doxorubicin—Infestation NOS—Temozolomide—malignant glioma	0.000163	0.0021	CcSEcCtD
Doxorubicin—Infestation—Temozolomide—malignant glioma	0.000163	0.0021	CcSEcCtD
Doxorubicin—ABCG2—telencephalon—malignant glioma	0.000163	0.00339	CbGeAlD
Doxorubicin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000162	0.00208	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00016	0.00205	CcSEcCtD
Doxorubicin—Stomatitis—Temozolomide—malignant glioma	0.000159	0.00204	CcSEcCtD
Doxorubicin—ABCC3—central nervous system—malignant glioma	0.000159	0.00331	CbGeAlD
Doxorubicin—Urinary tract infection—Temozolomide—malignant glioma	0.000159	0.00204	CcSEcCtD
Doxorubicin—POR—brain—malignant glioma	0.000158	0.00329	CbGeAlD
Doxorubicin—ABCC10—cerebellum—malignant glioma	0.000155	0.00322	CbGeAlD
Doxorubicin—Hepatobiliary disease—Temozolomide—malignant glioma	0.000154	0.00198	CcSEcCtD
Doxorubicin—Sinusitis—Temozolomide—malignant glioma	0.000153	0.00197	CcSEcCtD
Doxorubicin—Haemoglobin—Carmustine—malignant glioma	0.000152	0.00196	CcSEcCtD
Doxorubicin—Haemorrhage—Carmustine—malignant glioma	0.000152	0.00195	CcSEcCtD
Doxorubicin—Hypoaesthesia—Carmustine—malignant glioma	0.000151	0.00194	CcSEcCtD
Doxorubicin—Oedema peripheral—Carmustine—malignant glioma	0.000149	0.00192	CcSEcCtD
Doxorubicin—Connective tissue disorder—Carmustine—malignant glioma	0.000149	0.00191	CcSEcCtD
Doxorubicin—Haemoglobin—Temozolomide—malignant glioma	0.000147	0.00189	CcSEcCtD
Doxorubicin—Hepatitis—Temozolomide—malignant glioma	0.000147	0.00188	CcSEcCtD
Doxorubicin—Haemorrhage—Temozolomide—malignant glioma	0.000147	0.00188	CcSEcCtD
Doxorubicin—Visual impairment—Carmustine—malignant glioma	0.000146	0.00188	CcSEcCtD
Doxorubicin—Hypoaesthesia—Temozolomide—malignant glioma	0.000146	0.00187	CcSEcCtD
Doxorubicin—Pharyngitis—Temozolomide—malignant glioma	0.000146	0.00187	CcSEcCtD
Doxorubicin—Urinary tract disorder—Temozolomide—malignant glioma	0.000145	0.00186	CcSEcCtD
Doxorubicin—Oedema peripheral—Temozolomide—malignant glioma	0.000144	0.00185	CcSEcCtD
Doxorubicin—Connective tissue disorder—Temozolomide—malignant glioma	0.000144	0.00185	CcSEcCtD
Doxorubicin—Urethral disorder—Temozolomide—malignant glioma	0.000144	0.00184	CcSEcCtD
Doxorubicin—Eye disorder—Carmustine—malignant glioma	0.000142	0.00182	CcSEcCtD
Doxorubicin—Visual impairment—Temozolomide—malignant glioma	0.000141	0.00181	CcSEcCtD
Doxorubicin—Flushing—Carmustine—malignant glioma	0.000141	0.00181	CcSEcCtD
Doxorubicin—NQO1—brain—malignant glioma	0.000141	0.00293	CbGeAlD
Doxorubicin—Erythema multiforme—Temozolomide—malignant glioma	0.000139	0.00178	CcSEcCtD
Doxorubicin—Eye disorder—Temozolomide—malignant glioma	0.000137	0.00176	CcSEcCtD
Doxorubicin—Tinnitus—Temozolomide—malignant glioma	0.000137	0.00175	CcSEcCtD
Doxorubicin—Cardiac disorder—Temozolomide—malignant glioma	0.000136	0.00175	CcSEcCtD
Doxorubicin—Flushing—Temozolomide—malignant glioma	0.000136	0.00175	CcSEcCtD
Doxorubicin—Arrhythmia—Carmustine—malignant glioma	0.000136	0.00174	CcSEcCtD
Doxorubicin—Alopecia—Carmustine—malignant glioma	0.000134	0.00172	CcSEcCtD
Doxorubicin—Angiopathy—Temozolomide—malignant glioma	0.000133	0.00171	CcSEcCtD
Doxorubicin—Mental disorder—Carmustine—malignant glioma	0.000133	0.00171	CcSEcCtD
Doxorubicin—Immune system disorder—Temozolomide—malignant glioma	0.000132	0.0017	CcSEcCtD
Doxorubicin—Mediastinal disorder—Temozolomide—malignant glioma	0.000132	0.0017	CcSEcCtD
Doxorubicin—Malnutrition—Carmustine—malignant glioma	0.000132	0.0017	CcSEcCtD
Doxorubicin—Erythema—Carmustine—malignant glioma	0.000132	0.0017	CcSEcCtD
Doxorubicin—Chills—Temozolomide—malignant glioma	0.000132	0.00169	CcSEcCtD
Doxorubicin—Alopecia—Temozolomide—malignant glioma	0.00013	0.00166	CcSEcCtD
Doxorubicin—Mental disorder—Temozolomide—malignant glioma	0.000128	0.00165	CcSEcCtD
Doxorubicin—ABCG2—medulla oblongata—malignant glioma	0.000128	0.00266	CbGeAlD
Doxorubicin—Back pain—Carmustine—malignant glioma	0.000128	0.00164	CcSEcCtD
Doxorubicin—Erythema—Temozolomide—malignant glioma	0.000128	0.00164	CcSEcCtD
Doxorubicin—Malnutrition—Temozolomide—malignant glioma	0.000128	0.00164	CcSEcCtD
Doxorubicin—ABCC3—brain—malignant glioma	0.000126	0.00263	CbGeAlD
Doxorubicin—CYP2D6—brainstem—malignant glioma	0.000126	0.00262	CbGeAlD
Doxorubicin—ABCC10—brain—malignant glioma	0.000126	0.00261	CbGeAlD
Doxorubicin—Dysgeusia—Temozolomide—malignant glioma	0.000125	0.0016	CcSEcCtD
Doxorubicin—Vision blurred—Carmustine—malignant glioma	0.000124	0.0016	CcSEcCtD
Doxorubicin—CYP1B1—central nervous system—malignant glioma	0.000124	0.00259	CbGeAlD
Doxorubicin—Back pain—Temozolomide—malignant glioma	0.000123	0.00158	CcSEcCtD
Doxorubicin—Anaemia—Carmustine—malignant glioma	0.000122	0.00157	CcSEcCtD
Doxorubicin—CYP1B1—cerebellum—malignant glioma	0.000122	0.00253	CbGeAlD
Doxorubicin—Agitation—Carmustine—malignant glioma	0.000121	0.00156	CcSEcCtD
Doxorubicin—Vision blurred—Temozolomide—malignant glioma	0.00012	0.00154	CcSEcCtD
Doxorubicin—Ill-defined disorder—Temozolomide—malignant glioma	0.000118	0.00152	CcSEcCtD
Doxorubicin—Leukopenia—Carmustine—malignant glioma	0.000118	0.00152	CcSEcCtD
Doxorubicin—Anaemia—Temozolomide—malignant glioma	0.000118	0.00151	CcSEcCtD
Doxorubicin—Agitation—Temozolomide—malignant glioma	0.000117	0.00151	CcSEcCtD
Doxorubicin—ABCG2—midbrain—malignant glioma	0.000117	0.00244	CbGeAlD
Doxorubicin—Malaise—Temozolomide—malignant glioma	0.000115	0.00148	CcSEcCtD
Doxorubicin—Vertigo—Temozolomide—malignant glioma	0.000115	0.00147	CcSEcCtD
Doxorubicin—Convulsion—Carmustine—malignant glioma	0.000114	0.00147	CcSEcCtD
Doxorubicin—Leukopenia—Temozolomide—malignant glioma	0.000114	0.00147	CcSEcCtD
Doxorubicin—ABCG2—spinal cord—malignant glioma	0.000114	0.00238	CbGeAlD
Doxorubicin—Hypertension—Carmustine—malignant glioma	0.000114	0.00146	CcSEcCtD
Doxorubicin—Palpitations—Temozolomide—malignant glioma	0.000113	0.00145	CcSEcCtD
Doxorubicin—Chest pain—Carmustine—malignant glioma	0.000112	0.00144	CcSEcCtD
Doxorubicin—Myalgia—Carmustine—malignant glioma	0.000112	0.00144	CcSEcCtD
Doxorubicin—Anxiety—Carmustine—malignant glioma	0.000112	0.00144	CcSEcCtD
Doxorubicin—CYP2D6—telencephalon—malignant glioma	0.000112	0.00232	CbGeAlD
Doxorubicin—Cough—Temozolomide—malignant glioma	0.000111	0.00143	CcSEcCtD
Doxorubicin—Convulsion—Temozolomide—malignant glioma	0.000111	0.00142	CcSEcCtD
Doxorubicin—Hypertension—Temozolomide—malignant glioma	0.00011	0.00141	CcSEcCtD
Doxorubicin—ABCC1—cerebellum—malignant glioma	0.000109	0.00228	CbGeAlD
Doxorubicin—Confusional state—Carmustine—malignant glioma	0.000109	0.00139	CcSEcCtD
Doxorubicin—Myalgia—Temozolomide—malignant glioma	0.000109	0.00139	CcSEcCtD
Doxorubicin—Arthralgia—Temozolomide—malignant glioma	0.000109	0.00139	CcSEcCtD
Doxorubicin—Anxiety—Temozolomide—malignant glioma	0.000108	0.00139	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000108	0.00139	CcSEcCtD
Doxorubicin—Oedema—Carmustine—malignant glioma	0.000108	0.00138	CcSEcCtD
Doxorubicin—Discomfort—Temozolomide—malignant glioma	0.000107	0.00138	CcSEcCtD
Doxorubicin—Infection—Carmustine—malignant glioma	0.000107	0.00137	CcSEcCtD
Doxorubicin—Dry mouth—Temozolomide—malignant glioma	0.000106	0.00136	CcSEcCtD
Doxorubicin—Thrombocytopenia—Carmustine—malignant glioma	0.000106	0.00135	CcSEcCtD
Doxorubicin—Tachycardia—Carmustine—malignant glioma	0.000105	0.00135	CcSEcCtD
Doxorubicin—Confusional state—Temozolomide—malignant glioma	0.000105	0.00135	CcSEcCtD
Doxorubicin—Oedema—Temozolomide—malignant glioma	0.000104	0.00134	CcSEcCtD
Doxorubicin—Anaphylactic shock—Temozolomide—malignant glioma	0.000104	0.00134	CcSEcCtD
Doxorubicin—Infection—Temozolomide—malignant glioma	0.000103	0.00133	CcSEcCtD
Doxorubicin—Anorexia—Carmustine—malignant glioma	0.000103	0.00132	CcSEcCtD
Doxorubicin—Nervous system disorder—Temozolomide—malignant glioma	0.000102	0.00131	CcSEcCtD
Doxorubicin—Thrombocytopenia—Temozolomide—malignant glioma	0.000102	0.00131	CcSEcCtD
Doxorubicin—Skin disorder—Temozolomide—malignant glioma	0.000101	0.0013	CcSEcCtD
Doxorubicin—Hypotension—Carmustine—malignant glioma	0.000101	0.00129	CcSEcCtD
Doxorubicin—Hyperhidrosis—Temozolomide—malignant glioma	0.000101	0.00129	CcSEcCtD
Doxorubicin—Anorexia—Temozolomide—malignant glioma	9.93e-05	0.00127	CcSEcCtD
Doxorubicin—ABCB1—embryo—malignant glioma	9.88e-05	0.00206	CbGeAlD
Doxorubicin—CYP1B1—brain—malignant glioma	9.87e-05	0.00205	CbGeAlD
Doxorubicin—Musculoskeletal discomfort—Carmustine—malignant glioma	9.82e-05	0.00126	CcSEcCtD
Doxorubicin—Insomnia—Carmustine—malignant glioma	9.75e-05	0.00125	CcSEcCtD
Doxorubicin—Paraesthesia—Carmustine—malignant glioma	9.68e-05	0.00124	CcSEcCtD
Doxorubicin—Dyspnoea—Carmustine—malignant glioma	9.61e-05	0.00123	CcSEcCtD
Doxorubicin—Somnolence—Carmustine—malignant glioma	9.58e-05	0.00123	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Temozolomide—malignant glioma	9.49e-05	0.00122	CcSEcCtD
Doxorubicin—Insomnia—Temozolomide—malignant glioma	9.42e-05	0.00121	CcSEcCtD
Doxorubicin—Decreased appetite—Carmustine—malignant glioma	9.37e-05	0.0012	CcSEcCtD
Doxorubicin—Paraesthesia—Temozolomide—malignant glioma	9.35e-05	0.0012	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Carmustine—malignant glioma	9.3e-05	0.00119	CcSEcCtD
Doxorubicin—Dyspnoea—Temozolomide—malignant glioma	9.29e-05	0.00119	CcSEcCtD
Doxorubicin—Somnolence—Temozolomide—malignant glioma	9.26e-05	0.00119	CcSEcCtD
Doxorubicin—Pain—Carmustine—malignant glioma	9.22e-05	0.00118	CcSEcCtD
Doxorubicin—Constipation—Carmustine—malignant glioma	9.22e-05	0.00118	CcSEcCtD
Doxorubicin—Dyspepsia—Temozolomide—malignant glioma	9.17e-05	0.00118	CcSEcCtD
Doxorubicin—Decreased appetite—Temozolomide—malignant glioma	9.05e-05	0.00116	CcSEcCtD
Doxorubicin—ABCG2—cerebellum—malignant glioma	9.05e-05	0.00188	CbGeAlD
Doxorubicin—Gastrointestinal disorder—Temozolomide—malignant glioma	8.99e-05	0.00115	CcSEcCtD
Doxorubicin—Fatigue—Temozolomide—malignant glioma	8.98e-05	0.00115	CcSEcCtD
Doxorubicin—Pain—Temozolomide—malignant glioma	8.91e-05	0.00114	CcSEcCtD
Doxorubicin—Constipation—Temozolomide—malignant glioma	8.91e-05	0.00114	CcSEcCtD
Doxorubicin—Feeling abnormal—Carmustine—malignant glioma	8.88e-05	0.00114	CcSEcCtD
Doxorubicin—ABCC1—brain—malignant glioma	8.88e-05	0.00185	CbGeAlD
Doxorubicin—Gastrointestinal pain—Carmustine—malignant glioma	8.81e-05	0.00113	CcSEcCtD
Doxorubicin—ABCB1—retina—malignant glioma	8.73e-05	0.00182	CbGeAlD
Doxorubicin—Feeling abnormal—Temozolomide—malignant glioma	8.58e-05	0.0011	CcSEcCtD
Doxorubicin—CYP2B6—central nervous system—malignant glioma	8.54e-05	0.00178	CbGeAlD
Doxorubicin—Abdominal pain—Carmustine—malignant glioma	8.52e-05	0.00109	CcSEcCtD
Doxorubicin—Body temperature increased—Carmustine—malignant glioma	8.52e-05	0.00109	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Temozolomide—malignant glioma	8.52e-05	0.00109	CcSEcCtD
Doxorubicin—Urticaria—Temozolomide—malignant glioma	8.27e-05	0.00106	CcSEcCtD
Doxorubicin—Body temperature increased—Temozolomide—malignant glioma	8.23e-05	0.00106	CcSEcCtD
Doxorubicin—Abdominal pain—Temozolomide—malignant glioma	8.23e-05	0.00106	CcSEcCtD
Doxorubicin—ABCB1—telencephalon—malignant glioma	8.03e-05	0.00167	CbGeAlD
Doxorubicin—Hypersensitivity—Carmustine—malignant glioma	7.94e-05	0.00102	CcSEcCtD
Doxorubicin—Asthenia—Carmustine—malignant glioma	7.73e-05	0.000993	CcSEcCtD
Doxorubicin—Hypersensitivity—Temozolomide—malignant glioma	7.67e-05	0.000985	CcSEcCtD
Doxorubicin—Asthenia—Temozolomide—malignant glioma	7.47e-05	0.000959	CcSEcCtD
Doxorubicin—Diarrhoea—Carmustine—malignant glioma	7.37e-05	0.000947	CcSEcCtD
Doxorubicin—Pruritus—Temozolomide—malignant glioma	7.37e-05	0.000946	CcSEcCtD
Doxorubicin—ABCG2—brain—malignant glioma	7.35e-05	0.00153	CbGeAlD
Doxorubicin—Dizziness—Carmustine—malignant glioma	7.13e-05	0.000915	CcSEcCtD
Doxorubicin—Diarrhoea—Temozolomide—malignant glioma	7.13e-05	0.000915	CcSEcCtD
Doxorubicin—Dizziness—Temozolomide—malignant glioma	6.89e-05	0.000884	CcSEcCtD
Doxorubicin—Vomiting—Carmustine—malignant glioma	6.85e-05	0.00088	CcSEcCtD
Doxorubicin—Rash—Carmustine—malignant glioma	6.8e-05	0.000872	CcSEcCtD
Doxorubicin—Dermatitis—Carmustine—malignant glioma	6.79e-05	0.000872	CcSEcCtD
Doxorubicin—CYP2B6—brain—malignant glioma	6.78e-05	0.00141	CbGeAlD
Doxorubicin—Headache—Carmustine—malignant glioma	6.75e-05	0.000867	CcSEcCtD
Doxorubicin—Vomiting—Temozolomide—malignant glioma	6.62e-05	0.00085	CcSEcCtD
Doxorubicin—Rash—Temozolomide—malignant glioma	6.57e-05	0.000843	CcSEcCtD
Doxorubicin—Dermatitis—Temozolomide—malignant glioma	6.56e-05	0.000842	CcSEcCtD
Doxorubicin—Headache—Temozolomide—malignant glioma	6.52e-05	0.000838	CcSEcCtD
Doxorubicin—CYP3A4—central nervous system—malignant glioma	6.45e-05	0.00134	CbGeAlD
Doxorubicin—Nausea—Carmustine—malignant glioma	6.4e-05	0.000822	CcSEcCtD
Doxorubicin—CYP2D6—central nervous system—malignant glioma	6.35e-05	0.00132	CbGeAlD
Doxorubicin—ABCB1—medulla oblongata—malignant glioma	6.31e-05	0.00131	CbGeAlD
Doxorubicin—CYP2D6—cerebellum—malignant glioma	6.2e-05	0.00129	CbGeAlD
Doxorubicin—Nausea—Temozolomide—malignant glioma	6.19e-05	0.000794	CcSEcCtD
Doxorubicin—ABCB1—midbrain—malignant glioma	5.77e-05	0.0012	CbGeAlD
Doxorubicin—ABCB1—spinal cord—malignant glioma	5.63e-05	0.00117	CbGeAlD
Doxorubicin—CYP2D6—brain—malignant glioma	5.04e-05	0.00105	CbGeAlD
Doxorubicin—ABCB1—central nervous system—malignant glioma	4.57e-05	0.00095	CbGeAlD
Doxorubicin—ABCB1—cerebellum—malignant glioma	4.46e-05	0.000929	CbGeAlD
Doxorubicin—ABCB1—brain—malignant glioma	3.63e-05	0.000755	CbGeAlD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.06e-06	3.58e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NOTCH1—malignant glioma	3.05e-06	3.57e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CAV1—malignant glioma	3.04e-06	3.56e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.03e-06	3.55e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MYC—malignant glioma	3.02e-06	3.53e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PIK3CB—malignant glioma	3e-06	3.52e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PDGFB—malignant glioma	3e-06	3.52e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CAT—malignant glioma	3e-06	3.51e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.99e-06	3.5e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGFR1—malignant glioma	2.99e-06	3.5e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CD80—malignant glioma	2.99e-06	3.5e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—STAT3—malignant glioma	2.98e-06	3.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—APC—malignant glioma	2.98e-06	3.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CG—malignant glioma	2.98e-06	3.49e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—malignant glioma	2.98e-06	3.49e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PIK3CA—malignant glioma	2.97e-06	3.48e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FGF2—malignant glioma	2.97e-06	3.48e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTT1—malignant glioma	2.96e-06	3.47e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EGFR—malignant glioma	2.95e-06	3.45e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGF—malignant glioma	2.95e-06	3.45e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HIF1A—malignant glioma	2.94e-06	3.45e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP2B6—malignant glioma	2.94e-06	3.44e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTPN11—malignant glioma	2.93e-06	3.43e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NCOR1—malignant glioma	2.92e-06	3.43e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.91e-06	3.4e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTEN—malignant glioma	2.89e-06	3.39e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CG—malignant glioma	2.89e-06	3.39e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—malignant glioma	2.88e-06	3.37e-05	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AKT1—malignant glioma	2.86e-06	3.35e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—IDH1—malignant glioma	2.85e-06	3.34e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.85e-06	3.33e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CAV1—malignant glioma	2.85e-06	3.33e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NCOR1—malignant glioma	2.83e-06	3.31e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.82e-06	3.31e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTEN—malignant glioma	2.82e-06	3.3e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—BRAF—malignant glioma	2.8e-06	3.28e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GSTP1—malignant glioma	2.8e-06	3.28e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTEN—malignant glioma	2.79e-06	3.27e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PPARG—malignant glioma	2.79e-06	3.27e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—KRAS—malignant glioma	2.79e-06	3.26e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MDM2—malignant glioma	2.78e-06	3.25e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS1—malignant glioma	2.78e-06	3.25e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—AKT1—malignant glioma	2.77e-06	3.25e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CG—malignant glioma	2.77e-06	3.25e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MYC—malignant glioma	2.77e-06	3.25e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RAF1—malignant glioma	2.77e-06	3.24e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SPHK1—malignant glioma	2.76e-06	3.23e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ERBB2—malignant glioma	2.74e-06	3.21e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PIK3CB—malignant glioma	2.73e-06	3.2e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT2—malignant glioma	2.73e-06	3.19e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CAT—malignant glioma	2.73e-06	3.19e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EGFR—malignant glioma	2.71e-06	3.17e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—malignant glioma	2.71e-06	3.17e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PIK3CB—malignant glioma	2.7e-06	3.17e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2C18—malignant glioma	2.7e-06	3.16e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ASMT—malignant glioma	2.69e-06	3.15e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—IDH1—malignant glioma	2.68e-06	3.14e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—BAD—malignant glioma	2.68e-06	3.14e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PPARG—malignant glioma	2.67e-06	3.13e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOTCH1—malignant glioma	2.65e-06	3.11e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CD—malignant glioma	2.62e-06	3.07e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SPHK1—malignant glioma	2.6e-06	3.04e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD80—malignant glioma	2.6e-06	3.04e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL8—malignant glioma	2.6e-06	3.04e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTEN—malignant glioma	2.6e-06	3.04e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.6e-06	3.04e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APC—malignant glioma	2.59e-06	3.04e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—BCHE—malignant glioma	2.58e-06	3.02e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NCOR1—malignant glioma	2.57e-06	3.01e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGF—malignant glioma	2.56e-06	3e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—KRAS—malignant glioma	2.56e-06	3e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PIK3CA—malignant glioma	2.56e-06	3e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC5A5—malignant glioma	2.55e-06	2.98e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTPN11—malignant glioma	2.55e-06	2.98e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP2C18—malignant glioma	2.55e-06	2.98e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CD—malignant glioma	2.54e-06	2.98e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—BCAN—malignant glioma	2.53e-06	2.97e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—STAT3—malignant glioma	2.52e-06	2.95e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.51e-06	2.94e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FGF2—malignant glioma	2.51e-06	2.94e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CASP3—malignant glioma	2.49e-06	2.91e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—malignant glioma	2.48e-06	2.91e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—BRAF—malignant glioma	2.44e-06	2.85e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CD—malignant glioma	2.44e-06	2.85e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AKT1—malignant glioma	2.43e-06	2.84e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CAV1—malignant glioma	2.38e-06	2.79e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT2—malignant glioma	2.37e-06	2.78e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTEN—malignant glioma	2.36e-06	2.76e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PIK3CA—malignant glioma	2.35e-06	2.76e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MMP9—malignant glioma	2.35e-06	2.75e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MDM2—malignant glioma	2.35e-06	2.75e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MYC—malignant glioma	2.34e-06	2.74e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RAF1—malignant glioma	2.34e-06	2.74e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTEN—malignant glioma	2.34e-06	2.73e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ERBB2—malignant glioma	2.31e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CAV1—malignant glioma	2.31e-06	2.7e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EGFR—malignant glioma	2.29e-06	2.68e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CB—malignant glioma	2.28e-06	2.67e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CD—malignant glioma	2.28e-06	2.67e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.28e-06	2.67e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CB—malignant glioma	2.22e-06	2.59e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.2e-06	2.58e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—malignant glioma	2.19e-06	2.57e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL8—malignant glioma	2.19e-06	2.57e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTT1—malignant glioma	2.18e-06	2.56e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGF2—malignant glioma	2.18e-06	2.56e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CG—malignant glioma	2.17e-06	2.54e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KRAS—malignant glioma	2.16e-06	2.53e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CB—malignant glioma	2.12e-06	2.49e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.12e-06	2.48e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—malignant glioma	2.11e-06	2.47e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—malignant glioma	2.1e-06	2.46e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CG—malignant glioma	2.1e-06	2.46e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—malignant glioma	2.1e-06	2.46e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CAV1—malignant glioma	2.1e-06	2.46e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—malignant glioma	2.1e-06	2.46e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARG—malignant glioma	2.1e-06	2.45e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—malignant glioma	2.09e-06	2.45e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—STAT3—malignant glioma	2.09e-06	2.45e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTT1—malignant glioma	2.06e-06	2.41e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTP1—malignant glioma	2.05e-06	2.4e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS1—malignant glioma	2.05e-06	2.4e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MDM2—malignant glioma	2.04e-06	2.39e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PIK3CA—malignant glioma	2.04e-06	2.39e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—IDH2—malignant glioma	2.04e-06	2.39e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RAF1—malignant glioma	2.04e-06	2.38e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARG—malignant glioma	2.03e-06	2.37e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ERBB2—malignant glioma	2.01e-06	2.36e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CAT—malignant glioma	2e-06	2.34e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PIK3CA—malignant glioma	1.99e-06	2.33e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CB—malignant glioma	1.99e-06	2.33e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—malignant glioma	1.98e-06	2.32e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTEN—malignant glioma	1.97e-06	2.31e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PIK3CA—malignant glioma	1.97e-06	2.31e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—malignant glioma	1.97e-06	2.31e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—malignant glioma	1.94e-06	2.27e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS1—malignant glioma	1.93e-06	2.26e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—malignant glioma	1.92e-06	2.25e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.92e-06	2.25e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTEN—malignant glioma	1.91e-06	2.24e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CG—malignant glioma	1.91e-06	2.24e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CD—malignant glioma	1.91e-06	2.24e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—BCHE—malignant glioma	1.9e-06	2.23e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—malignant glioma	1.9e-06	2.22e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NCOR1—malignant glioma	1.89e-06	2.21e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC5A5—malignant glioma	1.88e-06	2.2e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CD—malignant glioma	1.85e-06	2.16e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARG—malignant glioma	1.84e-06	2.16e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTEN—malignant glioma	1.84e-06	2.15e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PIK3CA—malignant glioma	1.83e-06	2.15e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—BCHE—malignant glioma	1.79e-06	2.1e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KRAS—malignant glioma	1.79e-06	2.1e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—malignant glioma	1.78e-06	2.09e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.77e-06	2.07e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT3—malignant glioma	1.76e-06	2.07e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—IDH1—malignant glioma	1.76e-06	2.06e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.73e-06	2.03e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTEN—malignant glioma	1.72e-06	2.01e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SPHK1—malignant glioma	1.7e-06	1.99e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CD—malignant glioma	1.68e-06	1.97e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—malignant glioma	1.67e-06	1.95e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PIK3CA—malignant glioma	1.66e-06	1.95e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CB—malignant glioma	1.66e-06	1.95e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.66e-06	1.95e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—malignant glioma	1.65e-06	1.93e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PIK3CA—malignant glioma	1.65e-06	1.93e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—malignant glioma	1.64e-06	1.92e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—malignant glioma	1.62e-06	1.9e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—malignant glioma	1.61e-06	1.88e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CB—malignant glioma	1.61e-06	1.88e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—malignant glioma	1.6e-06	1.88e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—malignant glioma	1.59e-06	1.87e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—malignant glioma	1.59e-06	1.87e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CAV1—malignant glioma	1.54e-06	1.8e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT3—malignant glioma	1.54e-06	1.8e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KRAS—malignant glioma	1.52e-06	1.77e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTP1—malignant glioma	1.51e-06	1.77e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—malignant glioma	1.5e-06	1.75e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CAT—malignant glioma	1.47e-06	1.73e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CB—malignant glioma	1.46e-06	1.71e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—malignant glioma	1.45e-06	1.7e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTEN—malignant glioma	1.44e-06	1.68e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—malignant glioma	1.43e-06	1.67e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTP1—malignant glioma	1.43e-06	1.67e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CG—malignant glioma	1.4e-06	1.64e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—malignant glioma	1.4e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CA—malignant glioma	1.39e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NCOR1—malignant glioma	1.39e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTEN—malignant glioma	1.39e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CAT—malignant glioma	1.39e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—malignant glioma	1.36e-06	1.59e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARG—malignant glioma	1.35e-06	1.58e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CA—malignant glioma	1.35e-06	1.58e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—malignant glioma	1.35e-06	1.58e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTT1—malignant glioma	1.35e-06	1.58e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—malignant glioma	1.35e-06	1.58e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KRAS—malignant glioma	1.32e-06	1.54e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NCOR1—malignant glioma	1.31e-06	1.54e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CA—malignant glioma	1.29e-06	1.52e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTEN—malignant glioma	1.27e-06	1.48e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS1—malignant glioma	1.26e-06	1.48e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CD—malignant glioma	1.23e-06	1.44e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CA—malignant glioma	1.21e-06	1.42e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—BCHE—malignant glioma	1.17e-06	1.37e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.16e-06	1.36e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—malignant glioma	1.14e-06	1.33e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CAV1—malignant glioma	1.13e-06	1.33e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—malignant glioma	1.1e-06	1.29e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CB—malignant glioma	1.07e-06	1.26e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CAV1—malignant glioma	1.07e-06	1.25e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—malignant glioma	1.06e-06	1.25e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—malignant glioma	1.06e-06	1.24e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CG—malignant glioma	1.03e-06	1.21e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CA—malignant glioma	1.01e-06	1.19e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARG—malignant glioma	9.97e-07	1.17e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—malignant glioma	9.9e-07	1.16e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CA—malignant glioma	9.81e-07	1.15e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CG—malignant glioma	9.74e-07	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARG—malignant glioma	9.4e-07	1.1e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTP1—malignant glioma	9.33e-07	1.09e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTEN—malignant glioma	9.27e-07	1.09e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CD—malignant glioma	9.08e-07	1.06e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CAT—malignant glioma	9.08e-07	1.06e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CA—malignant glioma	8.93e-07	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NCOR1—malignant glioma	8.57e-07	1e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CD—malignant glioma	8.56e-07	1e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—malignant glioma	8.29e-07	9.71e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—malignant glioma	8.02e-07	9.39e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CB—malignant glioma	7.92e-07	9.27e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—malignant glioma	7.84e-07	9.19e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CB—malignant glioma	7.46e-07	8.74e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—malignant glioma	7.39e-07	8.66e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—malignant glioma	7.29e-07	8.54e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CAV1—malignant glioma	6.99e-07	8.18e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTEN—malignant glioma	6.84e-07	8.01e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CA—malignant glioma	6.54e-07	7.66e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTEN—malignant glioma	6.45e-07	7.55e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CG—malignant glioma	6.37e-07	7.45e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARG—malignant glioma	6.14e-07	7.19e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CD—malignant glioma	5.6e-07	6.55e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—malignant glioma	5.35e-07	6.26e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.88e-07	5.71e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—malignant glioma	4.83e-07	5.66e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CA—malignant glioma	4.83e-07	5.65e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CA—malignant glioma	4.55e-07	5.33e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTEN—malignant glioma	4.21e-07	4.94e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—malignant glioma	3.94e-07	4.62e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—malignant glioma	3.72e-07	4.35e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.97e-07	3.48e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—malignant glioma	2.43e-07	2.84e-06	CbGpPWpGaD
